相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
Jie Liu et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases
Carlien De Herdt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose
Mirella Hage et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
An Update on the Pathophysiology and Diagnosis of Inappropriate Secretion of Thyroid-Stimulating Hormone
Kenji Ohba
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test
Rulai Han et al.
THYROID (2020)
A 2019 update on TSH-secreting pituitary adenomas
P. Beck-Peccoz et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly
Carla Scaroni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Diagnostic approach to TSH-producing pituitary adenoma
Axel Tjornstrand et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Diagnosis and Treatment of Pituitary Adenomas A Review
Mark E. Molitch
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management
Fatemeh G. Amlashi et al.
ENDOCRINE (2016)
Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma
Noriaki Fukuhara et al.
ENDOCRINE JOURNAL (2015)
Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients
Frederique Rimareix et al.
THYROID (2015)
Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
Federico Gatto et al.
PITUITARY (2015)
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
Lisa Onnestam et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors
P. Beck-Peccoz et al.
EUROPEAN THYROID JOURNAL (2013)
Cure of a thyrotrophin (TSH)-secreting pituitary adenoma by medical therapy
Eric Fliers et al.
CLINICAL ENDOCRINOLOGY (2012)
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins
Federico Gatto et al.
CLINICAL ENDOCRINOLOGY (2012)
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5
Federico Gatto et al.
PITUITARY (2011)
Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2
Nadder Sharif et al.
ENDOCRINOLOGY (2007)
Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: A possible marker for predicting long-term response to octreotide therapy
Ai Yoshihara et al.
ENDOCRINE JOURNAL (2007)
Different responses to chronic somatostatin analogues in patients with central hyperthyroidism
D Mannavola et al.
CLINICAL ENDOCRINOLOGY (2005)
分享论文
